Lantheus Holdings Appoints Dr Jeffrey Humphrey As Chief Medical Officer and Dr Jean Claude Provost As Chief Science Officer
Lantheus Holdings Appoints Dr Jeffrey Humphrey As Chief Medical Officer and Dr Jean Claude Provost As Chief Science Officer
05/16/24, 9:46 AM
Location
bedfordIndustry
therapeutics
biotechnology
health care
Position
chief science officer
chief medical officer
Lantheus Holdings has appointed Dr Jeffrey Humphrey as chief medical officer (CMO) and Dr Jean-Claude Provost as chief science officer (CSO), effective May 28, 2024.
Company Info
Location
bedford, massachusetts, united states
Additional Info
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.